Accordingly, Nayak et al. [127] described that IKM5, an inhibitor of GRP78 (see also Section 5.2.1), inhibited cell invasion and EMT markers MMP-2, Twist1, and vimentin in MDA-MB-231 breast cancer cells. Here, HSPA5 is linked to breast carcinoma.